Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1430538rdf:typepubmed:Citationlld:pubmed
pubmed-article:1430538lifeskim:mentionsumls-concept:C0085393lld:lifeskim
pubmed-article:1430538lifeskim:mentionsumls-concept:C0026393lld:lifeskim
pubmed-article:1430538lifeskim:mentionsumls-concept:C0040900lld:lifeskim
pubmed-article:1430538pubmed:issue10lld:pubmed
pubmed-article:1430538pubmed:dateCreated1992-12-18lld:pubmed
pubmed-article:1430538pubmed:abstractTextSeven human immunodeficiency virus-(HIV) positive patients with biopsy proved extensive facial molluscum contagiosum were treated with trichloroacetic acid peels. Peels were performed with 25 to 50% trichloroacetic acid (average 35%) and were repeated every 2 weeks as needed. A total of 15 peels were performed with an average reduction in lesion counts of 40.5% (range 0 to 90%). No spread of molluscum lesions, scarring, or secondary infection developed at 2 months' follow-up. Trichloroacetic acid peeling in concentrations of 35% or less appears to be a safe, effective, adjuvant therapy in the treatment of extensive molluscum contagiosum in immunocompromised patients.lld:pubmed
pubmed-article:1430538pubmed:languageenglld:pubmed
pubmed-article:1430538pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1430538pubmed:citationSubsetIMlld:pubmed
pubmed-article:1430538pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1430538pubmed:statusMEDLINElld:pubmed
pubmed-article:1430538pubmed:monthOctlld:pubmed
pubmed-article:1430538pubmed:issn0148-0812lld:pubmed
pubmed-article:1430538pubmed:authorpubmed-author:RoenigkH...lld:pubmed
pubmed-article:1430538pubmed:authorpubmed-author:RobinsonJ KJKlld:pubmed
pubmed-article:1430538pubmed:authorpubmed-author:GarrettS JSJlld:pubmed
pubmed-article:1430538pubmed:issnTypePrintlld:pubmed
pubmed-article:1430538pubmed:volume18lld:pubmed
pubmed-article:1430538pubmed:ownerNLMlld:pubmed
pubmed-article:1430538pubmed:authorsCompleteYlld:pubmed
pubmed-article:1430538pubmed:pagination855-8lld:pubmed
pubmed-article:1430538pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1430538pubmed:meshHeadingpubmed-meshheading:1430538-...lld:pubmed
pubmed-article:1430538pubmed:meshHeadingpubmed-meshheading:1430538-...lld:pubmed
pubmed-article:1430538pubmed:meshHeadingpubmed-meshheading:1430538-...lld:pubmed
pubmed-article:1430538pubmed:meshHeadingpubmed-meshheading:1430538-...lld:pubmed
pubmed-article:1430538pubmed:meshHeadingpubmed-meshheading:1430538-...lld:pubmed
pubmed-article:1430538pubmed:meshHeadingpubmed-meshheading:1430538-...lld:pubmed
pubmed-article:1430538pubmed:meshHeadingpubmed-meshheading:1430538-...lld:pubmed
pubmed-article:1430538pubmed:year1992lld:pubmed
pubmed-article:1430538pubmed:articleTitleTrichloroacetic acid peel of molluscum contagiosum in immunocompromised patients.lld:pubmed
pubmed-article:1430538pubmed:affiliationDepartment of Dermatology, Northwestern University Medical School, Chicago, Illinois 60611.lld:pubmed
pubmed-article:1430538pubmed:publicationTypeJournal Articlelld:pubmed